UNSPSC 51442721: Technetium Tc-99m tetrofosmin or technetium 99mtc tetrofosmin

This classification denotes a radioconjugate with the molecular formula (C6H9N2O2)2./C6H8N2O2.TC,CL,CH3,B, a cardiac imaging contrast medium most often used in myocardial perfusion imaging, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UT0WHJ4951, more generally known as Technetium Tc 99m teboroxime. In general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer.

UNSPSC 51442721 Technetium Tc-99m tetrofosmin or technetium 99mtc tetrofosmin is a Commodity code nominally covering a radiopharmaceutical agent used in nuclear medicine imaging. The recent state and local opportunities posted under this code, however, show little alignment with the code's stated scope. The four most recent solicitations—from Maricopa County, Escambia County Correction, Broward County Aviation, and Pasco County—cover radiologic equipment procurement and installation, extended warranty services for X-ray machines, maintenance contracts for X-ray inspection systems, and as-needed supply of copper sulfate chemicals. None of these opportunities reflect procurement of the radiopharmaceutical product the code nominally describes. The mismatch suggests either systematic miscoding by issuing jurisdictions or that this code receives sporadic and off-scope tagging in state and local procurement systems.

The geographic spread of recent activity spans Arizona, Florida (Escambia, Broward, and Pasco counties), with no concentration evident and no repeat buyers appearing across the four opportunities. The most recent opportunity is Maricopa County's IFB 362910, posted October 1, 2026, soliciting radiologic equipment and installation services for three colleges with responses due October 22, 2026. Escambia County Correction posted a sole-source procurement (SSCORALM2526005) on August 12, 2026, for extended warranty coverage of X-ray machines, due August 19, 2026. Given the absence of relevant recent opportunities matching the code's radiopharmaceutical definition, firms pursuing medical supplies or nuclear medicine imaging products should verify code alignment through pre-bid contact before investing in proposal development under this Commodity code.